You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Twitter Demographics
Mendeley readers
Attention Score in Context
| Title |
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis
|
|---|---|
| Published in |
Annals of the Rheumatic Diseases, July 2023
|
| DOI | 10.1136/ard-2023-224416 |
| Pubmed ID | |
| Authors |
Ioannis Parodis, Charlotte Girard-Guyonvarc’h, Laurent Arnaud, Oliver Distler, Andrea Domján, Cornelia H M Van den Ende, Kim Fligelstone, Agnes Kocher, Maddalena Larosa, Martin Lau, Alexandros Mitropoulos, Mwidimi Ndosi, Janet L Poole, Anthony Redmond, Valentin Ritschl, Helene Alexanderson, Yvonne Sjöberg, Gunilla von Perner, Till Uhlig, Cecilia Varju, Johanna E Vriezekolk, Elisabet Welin, René Westhovens, Tanja A Stamm, Carina Boström |
| Abstract |
To develop evidence-based recommendations for the non-pharmacological management of systemic lupus erythematosus (SLE) and systemic sclerosis (SSc). A task force comprising 7 rheumatologists, 15 other healthcare professionals and 3 patients was established. Following a systematic literature review performed to inform the recommendations, statements were formulated, discussed during online meetings and graded based on risk of bias assessment, level of evidence (LoE) and strength of recommendation (SoR; scale A-D, A comprising consistent LoE 1 studies, D comprising LoE 4 or inconsistent studies), following the European Alliance of Associations for Rheumatology standard operating procedure. Level of agreement (LoA; scale 0-10, 0 denoting complete disagreement, 10 denoting complete agreement) was determined for each statement through online voting. Four overarching principles and 12 recommendations were developed. These concerned common and disease-specific aspects of non-pharmacological management. SoR ranged from A to D. The mean LoA with the overarching principles and recommendations ranged from 8.4 to 9.7. Briefly, non-pharmacological management of SLE and SSc should be tailored, person-centred and participatory. It is not intended to preclude but rather complement pharmacotherapy. Patients should be offered education and support for physical exercise, smoking cessation and avoidance of cold exposure. Photoprotection and psychosocial interventions are important for SLE patients, while mouth and hand exercises are important in SSc. The recommendations will guide healthcare professionals and patients towards a holistic and personalised management of SLE and SSc. Research and educational agendas were developed to address needs towards a higher evidence level, enhancement of clinician-patient communication and improved outcomes. |
Twitter Demographics
The data shown below were collected from the profiles of 213 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 16 | 8% |
| United States | 12 | 6% |
| Mexico | 10 | 5% |
| Colombia | 9 | 4% |
| France | 7 | 3% |
| United Kingdom | 6 | 3% |
| Italy | 5 | 2% |
| Japan | 5 | 2% |
| Peru | 5 | 2% |
| Other | 49 | 23% |
| Unknown | 89 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 159 | 75% |
| Scientists | 29 | 14% |
| Practitioners (doctors, other healthcare professionals) | 21 | 10% |
| Science communicators (journalists, bloggers, editors) | 4 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 12 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Unspecified | 3 | 25% |
| Other | 3 | 25% |
| Student > Ph. D. Student | 2 | 17% |
| Researcher | 2 | 17% |
| Professor | 1 | 8% |
| Other | 1 | 8% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 5 | 42% |
| Unspecified | 3 | 25% |
| Psychology | 1 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 8% |
| Social Sciences | 1 | 8% |
| Other | 1 | 8% |
Attention Score in Context
This research output has an Altmetric Attention Score of 175. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2023.
All research outputs
#217,730
of 24,520,187 outputs
Outputs from Annals of the Rheumatic Diseases
#79
of 7,646 outputs
Outputs of similar age
#4,262
of 341,412 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#3
of 150 outputs
Altmetric has tracked 24,520,187 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,646 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,412 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 150 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.